Tango Therapeutics Inc [NASDAQ: TNGX] gained 3.56% on the last trading session, reaching $8.28 price per share at the time.
Tango Therapeutics Inc represents 111.57 million in outstanding shares, while the company has a total market value of $1.12 billion with the latest information. TNGX stock price has been found in the range of $7.83 to $8.52.
If compared to the average trading volume of 2.88M shares, TNGX reached a trading volume of 5323322 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Tango Therapeutics Inc [TNGX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TNGX shares is $13.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TNGX stock is a recommendation set at 1.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Tango Therapeutics Inc shares, keeping their opinion on the stock as Peer Perform, with their previous recommendation back on November 18, 2025. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on August 19, 2025, representing the official price target for Tango Therapeutics Inc stock. Previously, the target price had yet another raise to $19, while Jefferies analysts kept a Buy rating on TNGX stock.
The Price to Book ratio for the last quarter was 5.78, with the Price to Cash per share for the same quarter was set at 1.14.
Trading performance analysis for TNGX stock
Tango Therapeutics Inc [TNGX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.02. With this latest performance, TNGX shares dropped by -7.84% in over the last four-week period, additionally plugging by 338.36% over the last 6 months – not to mention a rise of 168.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TNGX stock in for the last two-week period is set at 54.28, with the RSI for the last a single of trading hit 0.66, and the three-weeks RSI is set at 0.65 for Tango Therapeutics Inc [TNGX]. The present Moving Average for the last 50 days of trading for this stock 7.92, while it was recorded at 8.03 for the last single week of trading, and 4.78 for the last 200 days.
Tango Therapeutics Inc [TNGX]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Tango Therapeutics Inc [TNGX] shares currently have an operating margin of -165.91% and a Gross Margin at 96.36%. Tango Therapeutics Inc’s Net Margin is presently recorded at -151.15%.
Tango Therapeutics Inc (TNGX) Capital Structure & Debt Analysis
According to recent financial data for Tango Therapeutics Inc. ( TNGX), the Return on Equity (ROE) stands at -51.65%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -35.74%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Tango Therapeutics Inc’s Return on Invested Capital (ROIC) is -52.44%, showcasing its effectiveness in deploying capital for earnings.
Tango Therapeutics Inc (TNGX) Efficiency & Liquidity Metrics
Based on Tango Therapeutics Inc’s (TNGX) latest financial statements, the Debt-to-Equity Ratio is 0.22%, indicating its reliance on debt financing relative to shareholder equity.
Tango Therapeutics Inc (TNGX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Tango Therapeutics Inc. (TNGX) effectively leverages its workforce, generating an average of -$648516.13 per employee. The company’s liquidity position is robust, with a Current Ratio of 8.88% and a Quick Ratio of 8.88%, indicating strong ability to cover short-term liabilities.
Tango Therapeutics Inc [TNGX]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Tango Therapeutics Inc posted -0.34/share EPS, while the average EPS was predicted by analysts to be reported at -0.34/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TNGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tango Therapeutics Inc go to -5.06%.
An analysis of Institutional ownership at Tango Therapeutics Inc [TNGX]
There are presently around $98.44%, or 103.56%% of TNGX stock, in the hands of institutional investors. The top three institutional holders of TNGX stocks are: TRV GP IV, LLC with ownership of 19.2 million shares, which is approximately 17.7276%. ECOR1 CAPITAL, LLC, holding 13.33 million shares of the stock with an approximate value of $$114.38 million in TNGX stocks shares; and ECOR1 CAPITAL, LLC, currently with $$80.73 million in TNGX stock with ownership which is approximately 8.6868%.
